| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models. | Nat Biotechnol | 2010 | 3.15 |
| 2 | Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. | Proc Natl Acad Sci U S A | 2008 | 2.30 |
| 3 | The anti-CD30 monoclonal antibody SGN-30 promotes growth arrest and DNA fragmentation in vitro and affects antitumor activity in models of Hodgkin's disease. | Cancer Res | 2002 | 1.42 |